AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2014
Nov 7, 2014
30016_dirs_2014-11-07_07a4a039-ae0f-41f3-8992-b6806a99123d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2014-11-05
Reporting Person: AYERS JONATHAN W (Director, Chairman, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-11-05 | Common Stock | M | 29000 | $28.655 | Acquired | 445081 | Direct |
| 2014-11-05 | Common Stock | S | 12918 | $142.7578 | Disposed | 432163 | Direct |
| 2014-11-05 | Common Stock | S | 9895 | $143.7180 | Disposed | 422268 | Direct |
| 2014-11-05 | Common Stock | S | 6187 | $144.4737 | Disposed | 416081 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-11-05 | Non-Qualified Stock Option (right to buy) | $28.655 | M | 29000 | Disposed | 2015-02-02 | Common Stock (29000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 49000 | Indirect |
Footnotes
F1: Includes 45 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on 09/30/2014.
F2: The sale reported above was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 02/28/2014.
F3: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $142.20 to 143.19, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3, 4 and 5 to this Form 4.
F4: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $143.20 to $144.13, inclusive.
F5: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $144.21 to $144.64, inclusive.
F6: Grant of options to buy shares of common stock that became exercisable as to 20,000 shares on 02/03/2006, 02/03/2007, 02/03/2008 and 02/03/2009, and the remaining 16,512 shares on 02/03/2010.